ZanXRay
Board
1 director, since incorporationDirector (not named in the articles)
since 03-01-2024
term without a fixed end
listed in the 2025 annual accounts, filed on 22-09-2026
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
Board
Mandates as a list
-
- Director (not named in the articles), from 03-01-2024 to date
Control
Founder
This company
ZanXRay
Equity €189,188
Profit €186,047 in 2025
Capital
- Contribution
- €3,500
- Shares
- 1,000
- Contribution per share
- €3.50
- Equity per share
- €189 in 2025
- Source
- deed of 05-01-2024
Articles of association
deed of 05-01-2024 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- Rémunération des administrateurs, répartition des activités,rétributions,remboursement frais et vacations par écrit soumis au Code de DéontologieAssemblée générale fixe nombre,durée,pouvoirs si pluralité, un ou plusieurs actionnaires-médecins,au moins un actionnaire-médecin si co-administrateur non-actio…
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- Accord unanime autres actionnaires, cession entre vifs ou mort qu'avec accord unanime autres actionnaires et Code des Sociétés et alinéa premier
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Monday of June at 17:00
Shareholders
At incorporation
deed of 05-01-2024 ↗
- 1,000 shares (100%) · €3,500 in cash